ArticleReviews in cardiovascular medicine2026
A Single-Center Retrospective Analysis of the Diagnostic Efficacy of Transthoracic Echocardiography in the Classification of Patent Ductus Arteriosus.
Article in Reviews in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to investigate the diagnostic efficacy of transthoracic echocardiography (TTE) in classifying patent ductus arteriosus (PDA). Methods: A total of 616 patients diagnosed with PDA underwent TTE. TTE measurements were obtained using the parasternal short-axis view of the great arteries and the suprasternal fossa aortic long-axis view. Using digital subtraction angiography (DSA) as the gold standard, the diagnostic efficacy of TTE for PDA classification was evaluated. Results: Among true-positive cases correctly diagnosed by both TTE and DSA, the sensitivity for tubular PDA was 100.00%, and the specificity was 50.74%. For funnel-type PDA, the sensitivity was 50.57%, and the specificity was 100.00%. For a window-type PDA, the sensitivity was 60.00%, and the specificity was 100.00%. The internal diameters of the tubular PDA and the pulmonary artery side of the funnel-type PDA measured by TTE showed good agreement with those measured by DSA. In addition, in the suprasternal long-axis view of the ascending aorta (SSLAX-AA) of TTE among true-positive cases, the sensitivity for diagnosing tubular PDA was 100.00%, and the specificity was 75.25%; the sensitivity for funnel-type PDA was 75.51%, and the specificity was 100.00%; the sensitivity for window-type PDA was 66.67%, and the specificity was 100.00%. The diagnostic efficacy of this view was improved compared with the overall TTE, which may be due to the similarity between this view and the DSA view. Conclusions: Among true-positive cases, TTE has high sensitivity for diagnosing tubular PDA and high specificity for diagnosing funnel-type PDA. Meanwhile, TTE shows good agreement with DSA in measuring key parameters. Furthermore, TTE demonstrates stability in the diagnostic classification of PDA, with no significant influence from operator variability. TTE could serve as a reliable basis for clinical decision-making to aid in the diagnostic classification of PDA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.